We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MIP Technologies Signs Exclusive Distribution Agreement with Supelco

News   Dec 05, 2006

 
MIP Technologies Signs Exclusive Distribution Agreement with Supelco
 
 
 

RELATED ARTICLES

Personalized Immunotherapy Refined by Mass Spec-Machine Learning Pairing

News

A combination of mass spectrometry and a novel computational tool is more accurately identifying the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.

READ MORE

Fungus Chemistry May Mimic Opioids With Fewer Side Effects

News

The hunt for an opioid alternative has made a leap forward – a unique fungus may be able to mimic opioid suggesting it could be a safer less addictive drug, helping address the opioid epidemic of deaths by overdose.

READ MORE

Reducing Heart Attack-induced Tissue Damage by 30%

News

Scientists have discovered that inhibiting the synthesis of a lipid in a mouse suffering a heart attack reduces the tissue damage by 30%.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE